Determination of methadone and EDDP in oral fluid using the dried saliva spots sampling approach and gas chromatography-tandem mass spectrometry
The present work describes the development and validation of a novel approach to determine methadone (MTD) and its main metabolite (EDDP) in oral fluid samples, using the dried saliva spots (DSS) sampling approach and gas chromatography-tandem mass spectrometry (GC-MS/MS). Oral fluid samples (50 μL) were applied into Whatman™ 903 protein saver filter paper cards and were allowed to dry overnight. The extraction was carried out by immersion of the spot in 1 mL of isopropyl alcohol with agitation for 1 min. Afterwards, the extract was centrifuged for 15 min at 3500 rpm and the supernatant evaporated to dryness and reconstituted with 50 μL of methanol. The procedure was considered linear in the range of 10 to 250 ng/mL for both compounds, with determination coefficients greater than 0.99. Intra- and inter-day precision and accuracy revealed coefficients of variation (CVs) lower than 15% at the studied concentrations, with mean relative errors within ± 15% of the nominal concentrations. Recoveries ranged from 45 to 74%. The limits of detection and quantification were 5 and 10 ng/mL respectively for both analytes. All studied parameters complied with the defined criteria and the method enabled the successful determination of MTD and EDDP in oral fluid samples from patients undergoing opiate substitution/maintenance therapy.
KeywordsMethadone EDDP Oral fluid Dried saliva spots GC-MS/MS
This work is supported by FEDER funds through the POCI-COMPETE 2020 - Operational Programme Competitiveness and Internationalisation in Axis I – Strengthening Research, Technological Development and Innovation (Project POCI-01- 0145-FEDER-007491) and National Funds by FCT – Foundation for Science and Technology (Project UID/Multi /00709/2013).
Compliance with ethical standards
The present study was approved by the ethics committee from Casas de Santiago and has been conducted according to ethical standards. The analyzed samples belonged to individuals who gave an informed consent for their use (including the drug-free samples used in the validation experiments, provided by laboratory staff), and all analyses were carried out according to the ethical standards of the institution.
Conflict of interest
The authors declare that they have no conflicts of interest.
- 2.European Monitoring Centre for Drugs and Drug Adiction. European Drug Report 2018: trends and developments. Lisbo; 2018. https://www.emcdda.europa.eu/system/files/publications/8585/20181816_TDAT18001PTN_PDF.pdf. Accessed 3 July 2018.
- 4.Buchard A, Linnet K, Johansen SS, Munkholm J, Fregerslev M, Morling N. Postmortem blood concentrations of R- and S-enantiomers of methadone and EDDP in drug users: influence of co-medication and P-glycoprotein genotype. J Forensic Sci. 2010;55:457–63. https://doi.org/10.1111/j.1556-4029.2009.01278.x.CrossRefGoogle Scholar
- 5.Hui Diong S, Shuhadah N, Yusoff M, Sim MS, Elina R, Aziddin R, et al. Quantitation of methadone and metabolite in patients under maintenance treatment. J Anal Toxicol. 2014; 38:660–6. https://doi.org/10.1093/jat/bku096.
- 6.Lin H-R, Chen C-L, Huang C-L, Chen S-T, Lua A-C. Simultaneous determination of opiates, methadone, buprenorphine and metabolites in human urine by superficially porous liquid chromatography tandem mass spectrometry. J Chromatogr B. 2013;925:10–5. https://doi.org/10.1016/j.jchromb.2013.02.020.CrossRefGoogle Scholar
- 8.Meng L, Zhang W, Meng P, Zhu B, Zheng K. Comparison of hollow fiber liquid-phase microextraction and ultrasound-assisted low-density solvent dispersive liquid–liquid microextraction for the determination of drugs of abuse in biological samples by gas chromatography–mass spectrometry. J Chromatogr B. 2015;989:46–53. https://doi.org/10.1016/J.JCHROMB.2015.02.039.CrossRefGoogle Scholar
- 11.Rodriguez-Rosas ME, Lofwall MR, Strain EC, Siluk D, Wainer IW. Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry. J Chromatogr B. 2007;850:538–43. https://doi.org/10.1016/j.jchromb.2006.11.025.CrossRefGoogle Scholar
- 19.Toennes SW, Kauert GF, Steinmeyer S, Moeller MR. Driving under the influence of drugs - evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int. 2005;152:149–55. https://doi.org/10.1016/j.forsciint.2004.08.002.CrossRefGoogle Scholar
- 20.Wolff K, Hay A. Methadone in saliva. Clin Chem. 1991;37:1297–8.Google Scholar
- 22.Suzel Costa de Sousa Escada M. Métodos de análise de piperazinas em fluidos biológicos. Master Thesis. Universidade de Aveiro; 2007. https://docplayer.com.br/77754024-Universidade-de-aveiro-departamento-de-quimicamaria-suzel-costa-de-sousa-e-escada-metodos-de-analise-de-piperazinas-em-fluidos-biologicos.html. Accessed 3 July 2018.
- 23.Odoardi S, Anzillotti L, Strano-Rossi S. Simplifying sample pretreatment: application of dried blood spot (DBS) method to blood samples, including postmortem, for UHPLC–MS/MS analysis of drugs of abuse. Forensic Sci Int. 2014;243:61–7. https://doi.org/10.1016/j.forsciint.2014.04.015.CrossRefGoogle Scholar
- 26.Carvalho J, Rosado T, Barroso M, Gallardo E. Determination of antiepileptic drugs using dried saliva spots. J Anal Toxicol. 2018. https://doi.org/10.1093/jat/bky064.
- 29.Irie K, Shobu S, Hiratsuji S, Yamasaki Y, Nanjo S, Kokan C, et al. Development and validation of a method for gefitinib quantification in dried blood spots using liquid chromatography-tandem mass spectrometry: application to finger-prick clinical blood samples of patients with non-small cell lung cancer. J Chromatogr B. 2018;1087–1088:1–5. https://doi.org/10.1016/J.JCHROMB.2018.04.027.CrossRefGoogle Scholar
- 30.Torres L-M, Rivera-Espinosa L, Chávez-Pacheco JL, Navas CF, Demetrio JA, Alemón-Medina R, et al. A new method to quantify ifosfamide blood levels using dried blood spots and UPLC-MS/MS in paediatric patients with embryonic solid tumours. PLoS One. 2015;10:e0143421. https://doi.org/10.1371/journal.pone.0143421.CrossRefGoogle Scholar
- 31.Jager NG, Rosing H, Schellens JH, Beijnen JH. Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review. Bioanalysis. 2014. https://doi.org/10.4155/bio.14.185.
- 32.Food and Drug Administration. Guidance for industry bioanalytical method validation. 2001. https://www.fda.gov/downloads/drugs/guidances/ucm368107.pdf. Accessed 3 July 2018.
- 36.World Anti-Doping Agency. WADA Technical Document – TD2010IDCR Identification criteria for qualitative assays incorporating column chromatography and mass spectrometry. 2010. https://www.wada-ama.org/sites/default/files/resources/files/td2015idcr_-_eng.pdf. Accessed 2 July 2018.
- 38.Concheiro M, Gray TR, Shakleya DM, Huestis MA. High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem. 2010;398:915–24. https://doi.org/10.1007/s00216-010-3903-5.CrossRefGoogle Scholar
- 40.Liu HC, Lee HT, Hsu YC, Huang MH, Liu RH, Chen TJ, et al. Direct injection LC-MS-MS analysis of opiates, methamphetamine, buprenorphine, methadone and their metabolites in oral fluid from substitution therapy patients. J Anal Toxicol. 2015;39:472–80. https://doi.org/10.1093/jat/bkv041.CrossRefGoogle Scholar
- 43.Dams R, Murphy CM, Choo RE, Lambert WE, De Leenheer AP, Huestis MA. LC - atmospheric pressure chemical ionization-MS/MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation. Anal Chem. 2003;75:798–804. https://doi.org/10.1021/ac026111t.CrossRefGoogle Scholar